These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11700563)

  • 1. Crystal structure of the anthrax lethal factor.
    Pannifer AD; Wong TY; Schwarzenbacher R; Renatus M; Petosa C; Bienkowska J; Lacy DB; Collier RJ; Park S; Leppla SH; Hanna P; Liddington RC
    Nature; 2001 Nov; 414(6860):229-33. PubMed ID: 11700563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.
    Tonello F; Montecucco C
    Mol Aspects Med; 2009 Dec; 30(6):431-8. PubMed ID: 19665472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational insights into the interaction of the anthrax lethal factor with the N-terminal region of its substrates.
    Joshi M; Ebalunode JO; Briggs JM
    Proteins; 2009 May; 75(2):323-35. PubMed ID: 18831046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the anthrax toxin protective antigen.
    Petosa C; Collier RJ; Klimpel KR; Leppla SH; Liddington RC
    Nature; 1997 Feb; 385(6619):833-8. PubMed ID: 9039918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the cellular receptor for anthrax toxin.
    Bradley KA; Mogridge J; Mourez M; Collier RJ; Young JA
    Nature; 2001 Nov; 414(6860):225-9. PubMed ID: 11700562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of a complex between anthrax toxin and its host cell receptor.
    Santelli E; Bankston LA; Leppla SH; Liddington RC
    Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and biophysical characterization of the core protease domain of anthrax lethal factor.
    Gkazonis PV; Dalkas GA; Chasapis CT; Vlamis-Gardikas A; Bentrop D; Spyroulias GA
    Biochem Biophys Res Commun; 2010 Jun; 396(3):643-7. PubMed ID: 20438702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the anthrax lethal factor-substrate interaction and selectivity using docking and molecular dynamics simulations.
    Dalkas GA; Papakyriakou A; Vlamis-Gardikas A; Spyroulias GA
    Protein Sci; 2009 Aug; 18(8):1774-85. PubMed ID: 19585464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantification of anthrax lethal factor in serum by mass spectrometry.
    Boyer AE; Quinn CP; Woolfitt AR; Pirkle JL; McWilliams LG; Stamey KL; Bagarozzi DA; Hart JC; Barr JR
    Anal Chem; 2007 Nov; 79(22):8463-70. PubMed ID: 17929949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational dynamics of the anthrax lethal factor catalytic center.
    Dalkas GA; Chasapis CT; Gkazonis PV; Bentrop D; Spyroulias GA
    Biochemistry; 2010 Dec; 49(51):10767-9. PubMed ID: 21121613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.
    Vitale G; Bernardi L; Napolitani G; Mock M; Montecucco C
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):739-45. PubMed ID: 11104681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthrax toxins.
    Mourez M
    Rev Physiol Biochem Pharmacol; 2004; 152():135-64. PubMed ID: 15549606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulation of host signalling pathways by anthrax toxins.
    Turk BE
    Biochem J; 2007 Mar; 402(3):405-17. PubMed ID: 17313374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-association of the transmembrane domain of an anthrax toxin receptor.
    Go MY; Kim S; Partridge AW; Melnyk RA; Rath A; Deber CM; Mogridge J
    J Mol Biol; 2006 Jun; 360(1):145-56. PubMed ID: 16756998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
    Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
    J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosides.
    Lee LV; Bower KE; Liang FS; Shi J; Wu D; Sucheck SJ; Vogt PK; Wong CH
    J Am Chem Soc; 2004 Apr; 126(15):4774-5. PubMed ID: 15080670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized production and purification of Bacillus anthracis lethal factor.
    Park S; Leppla SH
    Protein Expr Purif; 2000 Apr; 18(3):293-302. PubMed ID: 10733882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of high-throughput assay of lethal factor using native substrate.
    Kim J; Choi MK; Koo BS; Yoon MY
    Anal Biochem; 2005 Jun; 341(1):33-9. PubMed ID: 15866525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of residue F552 in domain III of the protective antigen in the biological activity of anthrax lethal toxin.
    Khanna H; Gupta PK; Singh A; Chandra R; Singh Y
    Biol Chem; 2001 Jun; 382(6):941-6. PubMed ID: 11501759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the mosquito-larvicidal toxin Cry4Ba and its biological implications.
    Boonserm P; Davis P; Ellar DJ; Li J
    J Mol Biol; 2005 Apr; 348(2):363-82. PubMed ID: 15811374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.